SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-03-003817
Filing Date
2003-11-12
Accepted
2003-11-12 14:56:41
Documents
4
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 F0RM 10-Q w91477e10vq.htm 10-Q 374733
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER w91477exv31w01.htm EX-31.01 6240
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER w91477exv31w02.htm EX-31.02 6338
5 WRITTEN STATEMENT w91477exv32.htm EX-32 3243
  Complete submission text file 0000950133-03-003817.txt   392346
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 03993210
SIC: 2834 Pharmaceutical Preparations